Excessive GH and IGF-1 levels (>1 ng/mL and >age and sex-normalized IGF-1 levels above the upper limit of normal, respectively) are associated with multisystemic comorbidities, including congestive heart failure, sleep apnea, arthritis, impaired glucose tolerance, insulin resistance, and diabetes mellitus, as well as an elevated risk of mortality [1, 2, 4]. The gene discussed is IGF1; the disease is sleep apnea syndrome.